ID   JoPaca-1
AC   CVCL_S507
SY   JOPACA-1; JOPACA1; JoPaca1
DR   cancercelllines; CVCL_S507
DR   Cell_Model_Passport; SIDM01585
DR   DepMap; ACH-001353
DR   DSMZ; ACC-744
DR   DSMZCellDive; ACC-744
DR   Wikidata; Q28872926
RX   PubMed=23152778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 28 hours (PubMed=23152778); ~3-4 days (DSMZ=ACC-744).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=23152778; DepMap).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): DepMap; DSMZ
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 10
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 19
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 22.2,24
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 16
//
RX   PubMed=23152778; DOI=10.1371/journal.pone.0048503;
RA   Fredebohm J., Boettcher M., Eisen C., Gaida M.M., Heller A., Keleg S.,
RA   Tost J., Greulich-Bode K.M., Hotz-Wagenblatt A., Lathrop M.,
RA   Giese N.A., Hoheisel J.D.;
RT   "Establishment and characterization of a highly tumourigenic and
RT   cancer stem cell enriched pancreatic cancer cell line as a well
RT   defined model system.";
RL   PLoS ONE 7:E48503-E48503(2012).
//